Burlington Stores, Inc. Stock Compensation Disclosure
9. Stock-Based Compensation
On May 20, 2025, the Company’s stockholders approved an amendment to the Company's 2022 Omnibus Incentive Plan to, among other things, increase the number of shares of Company common stock subject to the plan by 3,100,000.
The Company accounts for awards issued under the Plans in accordance with Topic No. 718. As of January 31, 2026, there were 6,080,426 shares of common stock available for issuance under the Company's 2022 Omnibus Incentive Plan.
Non-cash stock compensation expense is as follows:
|
(in thousands) |
|
||||||||||
|
|
Fiscal Year Ended |
|
|||||||||
|
|
January 31, |
|
|
February 1, |
|
|
February 3, |
|
|||
Type of Non-Cash Stock Compensation |
|
2026 |
|
|
2025 |
|
|
2024 |
|
|||
Restricted stock unit grants (a) |
|
$ |
51,510 |
|
|
$ |
43,005 |
|
|
$ |
43,037 |
|
Stock option grants (a) |
|
|
16,441 |
|
|
|
19,543 |
|
|
|
19,502 |
|
Performance stock unit grants (a) |
|
|
38,781 |
|
|
|
25,024 |
|
|
|
21,409 |
|
Total (b) |
|
$ |
106,732 |
|
|
$ |
87,572 |
|
|
$ |
83,948 |
|
(a) Included in the line item “Selling, general and administrative expenses” in the Company’s Consolidated Statements of Income.
(b) The amounts presented in the table above exclude the effect of income taxes. The tax benefit related to the Company’s non-cash stock compensation was $19.3 million, $15.6 million and $15.5 million during Fiscal 2025, Fiscal 2024 and Fiscal 2023, respectively.
Stock Options
Options granted during Fiscal 2025, Fiscal 2024 and Fiscal 2023, were all service-based awards granted under the Plans at the following exercise prices:
|
|
Exercise Price Ranges |
|
|||||
|
|
From |
|
|
To |
|
||
Fiscal 2025 |
|
$ |
273.66 |
|
|
$ |
273.66 |
|
Fiscal 2024 |
|
$ |
178.02 |
|
|
$ |
290.34 |
|
Fiscal 2023 |
|
$ |
118.58 |
|
|
$ |
234.15 |
|
All awards granted during Fiscal 2025, Fiscal 2024 and Fiscal 2023 generally vest in one-fourth annual increments (subject to continued employment through the applicable vesting date). The final exercise date for any option granted is the tenth anniversary of the grant date. Options granted during Fiscal 2025, Fiscal 2024 and Fiscal 2023 become exercisable if the grantee’s employment is terminated without cause or, in some instances, the recipient resigns with good reason, within a certain period of time following a change in control. Unless determined otherwise by the plan administrator, upon cessation of employment other than for cause, the majority of options that have not vested will terminate immediately, and unexercised vested options will be exercisable for a period of 60 to 180 days.
As of January 31, 2026, the Company had 1,260,295 options outstanding to purchase shares of common stock, and there was $20.8 million of unearned non-cash stock-based option compensation that the Company expects to recognize as expense over a weighted average period of 1.9 years. The awards are expensed on a straight-line basis over the requisite service period. During Fiscal 2025, the Company eliminated stock option grants and shifted to granting more restricted stock units.
Stock option transactions during Fiscal 2025 are summarized as follows:
|
|
Number of |
|
|
Weighted |
|
||
Options outstanding, February 1, 2025 |
|
|
1,456,342 |
|
|
$ |
196.77 |
|
Options granted |
|
|
589 |
|
|
|
273.66 |
|
Options exercised (a) |
|
|
(150,964 |
) |
|
|
167.77 |
|
Options forfeited |
|
|
(45,672 |
) |
|
|
212.26 |
|
Options outstanding, January 31, 2026 |
|
|
1,260,295 |
|
|
|
199.72 |
|
(a) Options exercised during Fiscal 2025 had a total intrinsic value of $15.8 million.
The following table summarizes information about the stock options vested and expected to vest during the contractual term, as well as options exercisable:
|
|
Options |
|
|
Weighted |
|
|
Weighted |
|
|
Aggregate |
|
||||
Options vested and expected to vest |
|
|
1,260,295 |
|
|
|
6.1 |
|
|
$ |
199.72 |
|
|
$ |
124.3 |
|
Options exercisable |
|
|
813,227 |
|
|
|
5.2 |
|
|
$ |
207.55 |
|
|
$ |
75.0 |
|
During Fiscal 2025, the fair value of each stock option granted was estimated on the date of grant using the Black Scholes option pricing model. The fair value of each stock option granted during Fiscal 2025 was estimated using the following assumptions on a weighted average basis:
|
|
|
Fiscal Year Ended |
|
|
|
|
|
January 31, |
|
|
|
|
|
2026 |
|
|
Risk-free interest rate |
|
|
|
4.3 |
% |
Expected volatility |
|
|
|
42.3 |
% |
Expected life (years) |
|
|
|
4.0 |
|
Contractual life (years) |
|
|
|
10.0 |
|
Expected dividend yield |
|
|
|
0.0 |
% |
Grant date fair value of options issued |
|
$ |
106.01 |
|
|
The expected dividend yield was based on the Company’s expectation of not paying dividends in the near term. To evaluate its volatility factor, the Company uses the historical volatility of its stock price over the expected life of the options. The risk free interest rate was based on the U.S. Treasury rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the awards being valued. The expected life of the options was estimated using historical exercise rates.
Restricted Stock Units
Restricted stock units granted during Fiscal 2025 were all service-based awards. The fair value of each unit of restricted stock granted during Fiscal 2025 was based upon the closing price of the Company’s common stock on the grant date. Most of the awards outstanding as of January 31, 2026 have graded vesting provisions that generally vest in one-fourth annual increments (subject to continued employment through the applicable vesting date). Certain awards outstanding as of January 31, 2026 cliff vest at the end of a designated service period, ranging from two years to four years from the grant date. Awards granted to non-employee members of the Company’s Board of Directors vest 100% on the first anniversary of the grant date. Following a change of control, all unvested restricted stock units shall remain unvested, provided, however, that 100% of such shares shall vest if, following such change of control, the employment of the recipient is terminated without cause or, in some instances, the recipient resigns with good reason, within a certain period of time following a change in control.
As of January 31, 2026, there was approximately $96.9 million of unearned non-cash stock-based compensation related to restricted stock units that the Company expects to recognize as expense over a weighted average period of 2.5 years. The awards are expensed on a straight-line basis over the requisite service periods.
Award grant, vesting and forfeiture transactions during Fiscal 2025 are summarized as follows:
|
|
Number of |
|
|
Weighted |
|
||
Non-vested awards outstanding, February 1, 2025 |
|
|
653,406 |
|
|
$ |
190.83 |
|
Awards granted |
|
|
341,487 |
|
|
|
231.91 |
|
Awards vested (a) |
|
|
(224,732 |
) |
|
|
198.21 |
|
Awards forfeited |
|
|
(42,648 |
) |
|
|
201.97 |
|
Non-vested awards outstanding, January 31, 2026 |
|
|
727,513 |
|
|
|
207.18 |
|
Performance Share Units
The Company grants performance-based restricted stock units to its senior executives. Vesting of the performance stock units granted are based on continued service and the achievement of pre-established adjusted net income per share growth over a three-year performance period. Based on the Company’s achievement of these goals, each award may be earned up to 200% of the target award. In the event that actual performance is below threshold, no award will be made. Compensation costs recognized on the performance stock units are adjusted, as applicable, for performance above or below the target specified in the award.
As of January 31, 2026, there was approximately $44.9 million of unearned non-cash stock-based compensation related to performance share units that the Company expects to recognize as expense over a weighted average period of 1.7 years. The awards are expensed on a straight-line basis over the requisite service periods.
Performance share unit transactions during Fiscal 2025 are summarized as follows:
|
|
Number of |
|
|
Weighted |
|
||
Non-vested awards outstanding, February 1, 2025 |
|
|
292,870 |
|
|
$ |
188.37 |
|
Awards granted |
|
|
174,248 |
|
|
|
225.56 |
|
Awards vested (a) |
|
|
(99,388 |
) |
|
|
207.29 |
|
Awards forfeited |
|
|
(3,776 |
) |
|
|
196.30 |
|
Non-vested awards outstanding, January 31, 2026 |
|
|
363,954 |
|
|
|
200.92 |
|
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2026 | Mar 19, 2026 | Showing above |
| 2025 | Mar 17, 2025 | |
| 2024 | Mar 15, 2024 | |
| 2023 | Mar 13, 2023 | |
| 2022 | Mar 16, 2022 | |
| 2021 | Mar 15, 2021 | |
| 2020 | Mar 13, 2020 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.